Does international normalized ratio level predict pulmonary embolism?

Area of Science:

• Orthopedic Surgery
• Cardiology
• Pharmacology

Background:

• Pulmonary embolism (PE) prevention is critical after major musculoskeletal surgery, particularly joint arthroplasty.
• Existing guidelines recommend an international normalized ratio (INR) of 2-3 for warfarin anticoagulation, but higher INRs may increase bleeding and infection risks.
• Data on the optimal INR target for PE prevention post-arthroplasty remains inconsistent.

Purpose of the Study:

• To investigate whether an INR greater than 2 provides additional protection against pulmonary embolism in patients undergoing joint arthroplasty.
• To evaluate the relationship between INR levels and the incidence of pulmonary embolism after joint replacement surgery.

Main Methods:

• A retrospective study of 10,122 admissions for joint arthroplasty between 2004 and 2008.
• All patients received warfarin prophylaxis with a target INR of 2 or lower.
• Pulmonary embolism was assessed in 6% of admissions using CT, V/Q scan, or pulmonary angiography; 1.6% had confirmed PE.

Main Results:

• No significant difference in INR values was observed between patients with and without pulmonary embolism.
• Among patients with confirmed PE, 9% had an INR > 2, compared to 8% in those without PE.
• The study found no clinically relevant difference in INR values for patients who developed PE versus those who did not.

Conclusions:

• An INR target greater than 2 does not appear to offer additional protection against pulmonary embolism after joint arthroplasty.
• Balancing bleeding risk against PE risk is crucial when setting target INR levels.
• An INR below 2 may potentially reduce bleeding complications while still providing adequate PE prophylaxis.